Institutional Ownership
Ishares Tr
CUSIP 464288836U.S. PHARMA ETFIHEQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
194
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 2.77M | $239.87M |
| 2 | Foundations Investment Advisors, LLC | 689.3K | $59.75M |
| 3 | Morgan Stanley | 480.3K | $41.63M |
| 4 | Bank Of America Corp /De/ | 456.6K | $39.58M |
| 5 | Jpmorgan Chase & Co | 375.7K | $31.64M |
| 6 | Aptus Capital Advisors, LLC | 286.5K | $24.84M |
| 7 | Mcelhenny Sheffield Capital Management, LLC | 202.6K | $17.56M |
| 8 | Lpl Financial LLC | 170.2K | $14.75M |
| 9 | Anfield Capital Management, LLC | 129.6K | $11.23M |
| 10 | Insight Wealth Strategies, LLC | 118.7K | $10.29M |